Prevention means seeing the whole patient: Integrated arterial assessment as a cornerstone of cardiovascular care
Cardiovascular care is increasingly guided by contemporary clinical guidelines toward a more proactive, prevention-focused model, which emphasises early risk identification, lifetime risk estimation, and personalised prevention strategies. Rather than waiting for disease to become symptomatic, current prevention frameworks support earlier identification of vascular risk and intervention before major adverse events occur.
Traditionally, patients often entered cardiovascular pathways after symptoms had already developed: hypertension, diabetes complications or clearly manifested peripheral arterial disease (PAD).
The focus of clinical practice is shifting towards earlier detection of subclinical vascular disease, objective risk assessment, and long-term prevention planning, especially in preventive medicine, executive health, and longevity-focused clinic models.
Whether called preventive medicine, healthy ageing, proactive cardiovascular screening, or longevity-focused care, the underlying principle remains the same: prevention is no longer about isolated measurements.
The burden of Peripheral Arterial Disease
Peripheral arterial disease (PAD) remains one of the most under-recognised manifestations of systemic atherosclerosis.
Today, the disease affects over 230 million people worldwide, making it a major global health burden that continues to grow with ageing populations and rising prevalence of diabetes, hypertension, dyslipidaemia, obesity, and smoking.
However, PAD is not simply a lower-limb condition. It is a strong marker of systemic vascular disease and substantially elevated cardiovascular risk.
Patients with PAD face significantly higher risks of:
myocardial infarction
stroke
cardiovascular mortality
limb-threatening ischaemia
functional decline and reduced mobility
More concerning, many patients remain asymptomatic for years, meaning significant vascular disease could already be present before symptoms appear. For clinics focused on prevention, this is very important: a patient may seem healthy, active, and symptom-free, yet already carry a substantial vascular burden that routine consultation might miss.
Key risk factors include:
age
smoking history
diabetes
hypertension
hyperlipidaemia/obesity
family history of cardiovascular disease.
This makes arterial assessment highly relevant, not only in vascular settings but also in broader preventive and healthy ageing pathways.
Prevention is not just about grouping isolated measurements
Historically, cardiovascular prevention has often focused on individual risk markers such as blood pressure, cholesterol, glucose, and BMI. These remain critically important. However, contemporary prevention guidelines increasingly advocate for integrated risk assessment, which combines traditional risk factors with evidence of target organ damage, vascular function, and lifetime cardiovascular risk. The trend in modern preventive medicine is towards a more holistic view of risk, integrating:
arterial stiffness
blood pressure patterns
peripheral perfusion
validated risk scores
behavioural and lifestyle factors
This holistic approach increasingly aligns with the philosophy of longevity and healthy ageing clinics, where the goal is not just to diagnose existing disease but also to detect silent vascular risk before adverse events happen.
Holistic arterial assessment is a bridge between conventional screening and deeper cardiovascular insight.
By incorporating objective vascular measurements into preventive pathways, clinicians can move beyond theoretical risk assessments and assess the patient’s actual vascular condition. This includes, but is not limited to:
ABI (Ankle-Brachial Index) for detecting PAD
TBI (Toe-Brachial Index) for patients where ABI alone may be insufficient, particularly those with incompressible arteries
PWV (Pulse Wave Velocity) as a measure of arterial stiffness and vascular ageing
Averaging blood pressure for hypertension assessment
Bilateral arm blood pressure measurement to identify subclavian stenosis
SCORE2 calculation for guideline-based cardiovascular risk estimation.
PWV, in particular, has gained increasing importance as a marker of vascular ageing and arterial stiffness, supporting more advanced preventive strategies focused on cardiovascular age rather than solely on chronological age.
MESI’s Integrated Arterial Assessment concept
Instead of relying on multiple disconnected devices and fragmented workflows, Integrated Diagnostics allow clinics to perform a comprehensive cardiovascular and arterial assessment from a single platform. Beyond the above measurements, the MESI Protocol app enables clinics to create fully customised assessment pathways. This means each clinic can develop protocols tailored to its specific patient population and care models, focusing on preventive health checks, executive screening programmes, cardiovascular risk clinics, healthy ageing pathways and longevity-focused consultations
This level of workflow flexibility is increasingly vital in modern healthcare, where patient journeys are becoming more personalised and data driven.
Prevention is not just a list of separate figures. It is not merely blood pressure, cholesterol, or a risk score seen in isolation. True preventive medicine involves understanding how vascular, metabolic, and cardiac risks come together within the individual patient. It means recognising the whole person and their long-term cardiovascular journey. Prevention is about seeing the whole patient.